The FDA is moving at LIGHT SPEED ⚡️🇺🇸
✅ Cutting red tape on BIOSIMILARS to lower costs for your family
✅ MAHA Mission for supplement safety
✅ STOPPING the Screwworm parasite
✅ 1K+ NEW JOBS for top scientists
✅ Launching AEMS to modernize safety and save taxpayer dollars
FDA refuses to review Moderna’s influenza vaccine https://t.co/1D3Y5n5nRh
The quotes here are... quite a thing.
Vinay Prasad: "Your control arm does not reflect the best-available standard of care in the United States at the time of the study.”
Moderna: FDA previously said control arm was "acceptable."
Stephane Bancel: the decision the decision “does not further our shared goal of enhancing America’s leadership in developing innovative medicines."
$MRNA and also $PFE
The 2025 SODP Symposium on #DigitalMentalHealth & #AI is just a few days away on Dec 12, 1-3:30 PM ET!
Don't miss this FREE virtual event featuring: S. Choudhary (@mindmanure), @megkesh, K. Myrick, B. Nelson, @SteveSiddals, & Dr. Rahmani.
Register now: https://t.co/IHRfdilGJF
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory authority, STAT has learned. https://t.co/wSYaC0EpKG
Psychedelics have promise. But after losing my son, we can't ignore the dangers.
Thoughtful Opinion piece by Kristin Nash, who is doing great work.
https://t.co/Cz1qfKM6U8
#Breaking: Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial decisions about a treatment for boys with Duchenne muscular dystrophy. https://t.co/2rIEFT5Cvf
The FDA and NIH are moving away from animal testing, but do researchers think that's a good idea? @AAASMassMedia Fellow @marissarussoo and I spoke with 10+ researchers across academia and biotech to find out. Story via @statnews.
https://t.co/bVGF6QO3MY
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move, terminates work on other gene therapies
We'll be doing a bit more reporting on this. I'm reachable at [email protected] and JasonMast.05 on Signal
https://t.co/766WeV7fi0
STAGGERING: This new study of 133 countries is the first to estimate the impact of all USAID’s work. In 2 decades, it saved *92M* lives.
Current cuts, if not reversed, are forecast to cost *14M* lives thru 2030.
https://t.co/AFVhYRKvcQ
BREAKING: Beckley's 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
Read our analysis of the largest study of 5-MeO-DMT: https://t.co/I0VqOkjvTs
Psychedelic therapy from $ATAI and Beckley Psytech shows promise in mid-stage study in treatment-resistant depression https://t.co/g9WpaXoklO via @megkesh